MD Morris Reichlin (Head, Arthritis & Immunology Program, Oklahoma Medical Research Foundation & George Lynn Cross Research Professor of Medicine, Chief Rheumatology, Immunology & Allergy Section Oklahoma University Health Sciences Center)
{"title":"Significance of anti-ribosomal P antibodies","authors":"MD Morris Reichlin (Head, Arthritis & Immunology Program, Oklahoma Medical Research Foundation & George Lynn Cross Research Professor of Medicine, Chief Rheumatology, Immunology & Allergy Section Oklahoma University Health Sciences Center)","doi":"10.1016/S0197-1859(00)80038-2","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":100270,"journal":{"name":"Clinical Immunology Newsletter","volume":"19 3","pages":"Pages 25, 39-40"},"PeriodicalIF":0.0000,"publicationDate":"1999-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0197-1859(00)80038-2","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Immunology Newsletter","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0197185900800382","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}